An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of progress on proton therapy worldwide. For its part, RaySearch Laboratories AB, a Swedish medical technology company which develops software solutions for cancer treatment, has generated attention for multiple newsworthy developments.

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ability of radiology healthcare professionals to identify excess exposure to radiation in patients, which could result in both short- and long-term health effects. Understanding the effects of radiation on patients’ health and implementing effective radiation dose management through the adoption of innovative technologies can improve imaging practices and overall patient safety.